Oxidative modification of neurofilament-L and neuronal cell death induced by the catechol neurotoxin, tetrahydropapaveroline

Toxicology Letters

Volumn 217, Issue 1, 2013, Pages 59-66

  Kyeong, Inn Goo ^a   Eum, Won Sik ^b   Choi, Soo Young ^b   Kang, Jung Hoon ^a  

^a Chongju University   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Copper; Neurofilament L; Oxidative damage; Tetrahydropapaveroline

Indexed keywords

CARBONYL DERIVATIVE; CATECHOL; COPPER ION; GLUTAMIC ACID; LYSINE; NEUROFILAMENT L PROTEIN; NEUROFILAMENT PROTEIN; NEUROTOXIN; PROLINE; REACTIVE OXYGEN METABOLITE; SCAVENGER; TETRAHYDROPAPAVEROLINE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; INCUBATION TEMPERATURE; MOUSE; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN MODIFICATION;

ANIMALS; ASTROCYTES; CATECHOLS; CELL DEATH; CELL LINE; CELL SURVIVAL; COPPER; FREE RADICAL SCAVENGERS; MICE; MOLECULAR WEIGHT; NEURODEGENERATIVE DISEASES; NEUROFILAMENT PROTEINS; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; TETRAHYDROPAPAVEROLINE;

EID: 84872130503     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.11.029     Document Type: Article

References (55)

1. Brown D.R., Qin K., Herms J.W., Madlung A., Manson J., Strome R., Fraser P.E., Kruck T., Bohlen A., Schulz-Schaeffer W., Giese A., Westaway D., Kretzschmar H. The cellular prion protein binds copper in vivo. Nature (London) 1997, 390:684-687.
2. Ching G.Y., Liem R.K. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. Journal of Cell Biology 1993, 122:1323-1335.
3. Choi W.S., Yoon S.Y., Oh T.H., Choi E.J., O'Malley K.L., Oh Y.J. Two distinct mechanisms are involved in 6-hydroxydopamine-and Mpp+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. Journal of Neuroscience Research 1999, 57:86-94.
4. Collard J.F., Cote F., Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995, 375:61-64.
5. Davies M.J. The oxidative environment and protein damage. Biochimica et Biophysica Acta 2005, 1703:93-109.
6. Forno L.S. Lewy bodies. New England Journal of Medicine 1986, 314:122.
7. Geisler N., Kaufmann E., Fischer S., Plessmann U., Weber K. Neurofilament architecture combine structural principles of intermeadiate filaments with carboxy-terminal extensions increasing in size between triplet proteins. EMBO Journal 1983, 2:1295-1302.
8. Grune T., Reinheckel T., Davies K.J. Degradation of oxidized proteins in mammalian cells. FASEB Journal 1997, 11:526-534.
9. Halliwell B., Gutteridge J.M.C. Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Letters 1992, 307:108-112.
10. Hill W.D., Lee V.M., Huritig H.I., Murray J.M., Trojanowski J.Q. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies. Journal of Comparative Neurology 1991, 309:150-160.
11. Hugli T.E., Moore S. Determination of the tryptophan content of proteins by ion exchange chromatography of alkaline hydrolysates. Journal of Biological Chemistry 1972, 247:2828-2834.
12. Imlay J.A., Chin S.M., Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 1988, 240:640-642.
13. Julien J.P., Mushynski W.E. Neurofilaments in health and disease. Progress in Nucleic Acid Research and Molecular Biology 1998, 61:1-23.
14. Jung Y., Surh Y. Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free Radical Biology and Medicine 2001, 30:1407-1417.
15. Kim N.H., Kang J.H. Oxidative modification of neurofilament-L by copper-catalyzed reaction. Journal of Biochemistry and Molecular Biology 2003, 36:488-492.
16. Kim N.H., Jeong M.S., Choi S.Y., Kang J.H. Oxidative modification of neurofilament-L by the Cu, Zn-superoxide dismutase and bhydrogen peroxide system. Biochimie 2004, 86:553-559.
17. Kang J.H. Oxidative modification of neurofilament-L by the cytochrome c and hydrogen peroxide system. Bulletin of the Korean Chemical Society 2007, 28:77-80.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
19. Lee M.K., Xu Z., Wong P.C., Cleveland D.W. Neurofilaments are obligate heteropolymers in vivo. Journal of Cell Biology 1993, 122:1337-1350.
20. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods in Enzymology 1994, 233:346-357.
21. Ma D., Descarries L., Micheva K.D., Lepage Y., Julien J.P., Doucet G. Severe neuronal losses with age in the parietal cortex and ventrobasal thalamus of mice transgenic for the human NF-L neurofilament protein. Journal of Comparative Neurology 1999, 406:433-448.
22. Maisonneuve E., Ezraty B., Dukan S. Protein aggregates: an aging factor involved in cell death. Journal of Bacteriology 2008, 190:6070-6075.
23. Maruyama W., Sango K., Iwasa K., Minami C., Dostert P., Kawai M., Moriyasu M., Naoi M. Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3',4'-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced by tetrahydropapaverolines. Neuroscience Letters 2000, 291:89-92.
24. Middeldorp J., van den Berge S.A., Aronica E., Speijer D., Hol E.M. Specific human astrocyte subtype revealed by affinity purified GFAP antibody; unpurified serum cross-reacts with neurofilament-L in Alzheimer. PLoS ONE 2009, 4:e7663.
25. Mirzaei H., Regnier F. Protein:protein aggregation induced by protein oxidation. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2008, 873:8-14.
26. Multhaup G., Schlicksupp A., Hesse L., Behler D., Ruppert T., Masters C.L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 1996, 271:1406-1409.
27. Murray J., Oquendo C.E., Willis J.H., Marusich M.F., Capaldi R.A. Monitoring oxidative and nitrative modification of cellular proteins; a paradigm for identifying key disease related markers of oxidative stress. Advanced Drug Delivery Reviews 2008, 60:1497-1503.
28. Nixon R.A., Lewis S.E. Differential turnover of phosphate groups on neurofilament subunits in mammalian neurons in vivo. Journal of Biological Chemistry 1986, 261:16298-16301.
29. Nixon R.A., Shea T.B. Dynamics of neuronal intermediate filaments: a developmental perspective. Cell Motility and the Cytoskeleton 1992, 22:81-91.
30. Nyström T. Role of oxidative carbonylation in protein quality control and senescence. EMBO Journal 2005, 24:1311-1317.
31. Olzscha H., Schermann S.M., Woerner A.C., Pinket S., Hecht M.H., Tartaglia G.G., Vendruscolo M., Hayer-Hartl M., Hartl F.U., Vabulas R.M. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 2011, 144:67-78.
32. Pall H.S., Williams A.C., Blake D.R., Lunec J., Gutteridge J.M., Hall M., Taylor A. Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet 1987, 2:238-241.
33. Pant H.C., Veeranna Neurofilament phosphorylation. Biochemistry and Cell Biology 1995, 73:575-592.
34. Park S.H., Jang J.H., Li M.H., Na H.K., Cha Y.N., Surh Y.J. Nrf2-mediated heme oxygenase-1 induction confers adaptive survival response to tetrahydropapaveroline-induced oxidative PC12 cell death. Antioxidants and Redox Signaling 2007, 9:2075-2086.
35. Perluigi M., Joshi G., Sultana R., Calabrese V., De Marco C., Coccia R., Butterfield D.A. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress. Neuroscience 2006, 138:1161-1170.
36. Pollanen M.S., Dickson D.W., Bergeron C. Pathology and biology of the Lewy body. Journal of Neuropathology and Experimental Neurology 1993, 52:183-191.
37. Rahner N., Holzmann C., Krüger R., Schöls L., Berger K., Riess O. Neurofilament L gene is not a genetic factor of sporadic and familial Parkinson's disease. Brain Research 2002, 951:82-86.
38. Refsgaardm H.H., Tsai L., Stadman E.R. Modification of proteins by polyunsaturated fatty acid peroxidation products. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:611-616.
39. Reznick A.Z., Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods in Enzymology 1994, 233:357-363.
40. Riess O., Kuhn W., Kruger R. Genetic influence on the development of Parkinson's disease. Journal of Neurology 2000, 247:II69-II74.
41. Sagripanti J.L., Kraemer K.H. Site-specific oxidative DNA damage at polyguanosines produced by copper plus hydrogen peroxide. Journal of Biological Chemistry 1989, 264:1729-1734.
42. Sandler M., Carter S.B., Hunter K.R., Stern G.M. Tetrahydroisoquinoline alkaloids: in vivo metabolites of l-DOPA in man. Nature 1973, 241:439-443.
43. Shepherd C.E., MoCann H., Thiel E., Halliday G.M. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies. Neurobiology of Disease 2002, 9:249-257.
44. Shin M.H., Jang J.H., Surh Y.J. Potential roles of NF-κappaB and ERK1/2 in cytoprotection against oxidative cell death induced by tetrahydropapaveroline. Free Radical Biology and Medicine 2004, 36:1185-1194.
45. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Analytical Biochemistry 1985, 150:76-85.
46. Smith M.A., Rudnicka-Nawrot M., Richey P.L., Praprotnik D., Mulvihill P., Miller C.A., Sayre L.M., Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. Journal of Neurochemistry 1995, 64:2660-2666.
47. Soh Y., Shin M.H., Lee J.S., Jang J.H., Kim O.H., Kang H., Surh Y.J. Oxidative DNA damage and glioma cell death induced by tetrahydropapaverolkine. Mutation Research 2003, 544:129-142.
48. Soto-Otero R., Sanmartin-Suarez C., Sanchez-Iglesias S., Hermida-Ameijeiras A., Sanchez-Sellero I., Mendez-Alvarez E. Study on the ability of 1,2,3,4-tetrahydropapaveroline to cause oxidative stress: mechanisms and potential implications in relation to Parkinson's disease. Journal of Biochemical and Molecular Toxicology 2006, 20:209-220.
49. Stadtman E.R. Oxygen radical-mediated damage of enzymes: biological implications. Medical, Biochemical and Chemical Aspects of Free Radicals 1989, 11-25. Elsevier, Amsterdam. O. Hayashi, E. Niki, M. Kondo, T. Yoshikawa (Eds.).
50. Surh Y.J., Jung Y.J., Jang J., Lee J.S., Yoon H.R. Iron enhancement of oxidative DNA damage and neuronal cell death induced by salsolinol. Journal of Toxicology and Environmental Health: Part A 2002, 65:473-488.
51. Teunissen C.E., Iacobaeus E., Khademi M., Brundin L., Norgren N., Koel-Simmelink M.J., Schepens M., Bouwman F., Twaalfhoven H.A., Blom H.J., jakobs C., Dijkstra C.D. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 2009, 72:1322-1329.
52. Wanpen S., Govitrapong P., Shavali S., Sangchot P., Ebadi M. Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein. Brain Research 2004, 1005:67-76.
53. Wu Y., Blum D., Nisou M.-F., Benabid N.-A., Verna J.-M. Unlike MPP+, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition. Neuroscience Letters 1996, 221:69-71.
54. Xu Z., Cork L.C., Griffin J.W., Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 1993, 73:23-33.
55. Zhai J., Lin H., Julien J.P., Schlaepfer W.W. Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charot-Marie-Tooth disease-linked mutations in NFL and HSPB1. Human Molecular Genetics 2007, 16:3103-3116.